Microbix Biosystms Statistics
Want to see TSE:MBX full AI Analyst Report?
Microbix Biosystms (MBX) Stock Statistics & Valuation Metrics
Total Valuation
Microbix Biosystms has a market cap or net worth of CAD 40.41M. The enterprise value is CAD 40.83M.
- Market Cap
- CAD 40.41M
- Enterprise Value
- CAD 40.83M
Share Statistics
Microbix Biosystms has 136,968,660 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 136,968,660
- Owned by Insiders
- 4.12%
- Owned by Institutions
- ―
Financial Efficiency
Microbix Biosystms’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -4.41%.
- Return on Equity (ROE)
- -0.08
- Return on Assets (ROA)
- -0.06
- Return on Invested Capital (ROIC)
- -4.41%
- Return on Capital Employed (ROCE)
- -0.05
- Revenue Per Employee
- 185.85K
- Profits Per Employee
- -22.46K
- Employee Count
- 100
- Asset Turnover
- 0.50
- Inventory Turnover
- 0.95
Valuation Ratios
The current PE Ratio of Microbix Biosystms is -7.79. Microbix Biosystms’s PEG ratio is 0.06.
- PE Ratio
- -7.79
- PS Ratio
- 2.45
- PB Ratio
- 1.52
- Price to FCF
- -9.69
- Price to Operating Cash Flow
- -11.23
- PEG Ratio
- 0.06
Income Statement
In the last 12 months, Microbix Biosystms had revenue of 18.59M and earned -2.25M in profits. Earnings per share was -0.02.
- Revenue
- 18.59M
- Gross Profit
- 9.85M
- Operating Income
- -1.58M
- Pretax Income
- -2.30M
- Net Income
- -2.25M
- EBITDA
- 428.23K
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -3.29M and capital expenditures -595,167, giving a free cash flow of -3.89M billion.
- Operating Cash Flow
- -3.29M
- Free Cash Flow
- -3.89M
- Free Cash Flow per Share
- -0.03
Dividends & Yields
Microbix Biosystms pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -10.32%
- Earnings Yield
- -13.21%
Stock Price Statistics
- Beta
- 0.06
- 52-Week Price Change
- 17.02%
- 50-Day Moving Average
- 0.30
- 200-Day Moving Average
- 0.28
- Relative Strength Index (RSI)
- 43.20
- Average Volume (3m)
- 27.94K
Important Dates
Microbix Biosystms upcoming earnings date is Dec 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Dec 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Microbix Biosystms as a current ratio of 8.48, with Debt / Equity ratio of 24.36%
- Current Ratio
- 8.48
- Quick Ratio
- 5.17
- Debt to Market Cap
- 0.14
- Net Debt to EBITDA
- -12.48
- Interest Coverage Ratio
- -1.66
Taxes
In the past 12 months, Microbix Biosystms has paid -55.73K in taxes.
- Income Tax
- -55.73K
- Effective Tax Rate
- 0.02
Enterprise Valuation
Microbix Biosystms EV to EBITDA ratio is -16.18, with an EV/FCF ratio of -9.57.
- EV to Sales
- 2.42
- EV to EBITDA
- -16.18
- EV to Free Cash Flow
- -9.57
- EV to Operating Cash Flow
- -11.30
Balance Sheet
Microbix Biosystms has CAD 7.16M in cash and marketable securities with CAD 6.72M in debt, giving a net cash position of CAD 440.07K billion.
- Cash & Marketable Securities
- CAD 7.16M
- Total Debt
- CAD 6.72M
- Net Cash
- CAD 440.07K
- Net Cash Per Share
- CAD 0.00
- Tangible Book Value Per Share
- CAD 0.16
Margins
Gross margin is 45.90%, with operating margin of -27.69%, and net profit margin of -31.72%.
- Gross Margin
- 45.90%
- Operating Margin
- -27.69%
- Pretax Margin
- -32.08%
- Net Profit Margin
- -31.72%
- EBITDA Margin
- -14.94%
- EBIT Margin
- -27.03%
Analyst Forecast
The average price target for Microbix Biosystms is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -27.13%
- EPS Growth Forecast
- -1752.63%
Scores
- Smart Score
- ―
- AI Score
- 54

